Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 2 institutions in 1 country.
Liz F Sánchez-PalenciaÀrea de Parasitologia, Departament Farmàcia i Tecnologia Farmacèutica i Parasitologia, Universitat de València, 46100 Burjassot, Spain.
María TrelisÀrea de Parasitologia, Departament Farmàcia i Tecnologia Farmacèutica i Parasitologia, Universitat de València, 46100 Burjassot, Spain.ORCID 0000-0002-5977-3337
Julio López-AbánGrupo de Enfermedades Infecciosas y Tropicales (e-INTRO), IBSAL-CIETUS (Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca), Facultad de Farmacia, Universidad de Salamanca, Méndez Nieto s/n, 37007 Salamanca, Spain.
Alicia GalianoÀrea de Parasitologia, Departament Farmàcia i Tecnologia Farmacèutica i Parasitologia, Universitat de València, 46100 Burjassot, Spain.
Belén VicenteGrupo de Enfermedades Infecciosas y Tropicales (e-INTRO), IBSAL-CIETUS (Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca), Facultad de Farmacia, Universidad de Salamanca, Méndez Nieto s/n, 37007 Salamanca, Spain.
Esther Del OlmoDepartamento de Ciencias Farmacéuticas: Química Farmacéutica, Facultad de Farmacia, Universidad de Salamanca, IBSAL CIETUS, 37007 Salamanca, Spain.
Antonio MuroGrupo de Enfermedades Infecciosas y Tropicales (e-INTRO), IBSAL-CIETUS (Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca), Facultad de Farmacia, Universidad de Salamanca, Méndez Nieto s/n, 37007 Salamanca, Spain.ORCID 0000-0003-0244-4740
Dolores BernalDepartament de Bioquímica i Biologia Molecular, Universitat de València, 46100 Burjassot, Spain.
Antonio MarcillaÀrea de Parasitologia, Departament Farmàcia i Tecnologia Farmacèutica i Parasitologia, Universitat de València, 46100 Burjassot, Spain.ORCID 0000-0003-0004-0531
Universitat de València · ESUniversidad de Salamanca · ES
Funding
Department of Education, Culture and Sports, Generalitat Valenciana, Valencia, Spain PROMETEO/2020/071State Research Agency, Ministry of Science and Innovation, Spain RICET RD16/0027/0018; PI19/01727; RTI2018-099474-B-I00; PID2019-105713GB-I00/AEI/10.13039/501100011033Valencia City Council-Universitat de València Juan Castelló doctoral scholarship
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Evaluation of the Immunomodulatory Effect of the Recombinant 14-3-3 and Major Antigen Proteins of · full record | OpenQuestion